Bionexo
PrivateLast Round
Growth Equity
Oct 20, 2023
Est. Valuation
$200.2M
Total Funding Raised
$101.6M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Bionexo is a health tech company that provides an integrated suite of cloud software and a B2B marketplace to help hospitals and healthcare providers source critical care products and manage supply chain processes.
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, Supply Chain, Pharma Supply Chain, Healthcare Analytics, E-commerce
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bionexo Comparables
Compare Bionexo with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GHX Europe | 78% | |
| Procurement Partners | 67% | |
| Huma Tecnologia | 66% |
Bionexo Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Oct 20, 2023 | ||||
| Growth Equity | Oct 15, 2021 | ||||
| VC Round | Dec 13, 2018 | ||||
| Private Equity | Mar 24, 2017 | ||||
| VC Round | Jul 17, 2012 |
Key People
Founding team and executive leadership
Bionexo Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Temasek | Growth Equity |
| Apus Capital | Growth Equity |
| Bain Capital, LP | Growth Equity |
| Insight Partners | VC Round |
| Prisma Capital | Growth Equity, Private Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 38% MoM.
- Jul 23, 2026
Grew 73% QoQ, from 509 to 882 employees.
Bionexo Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Bionexo's valuation, stock price, and market status.
Is Bionexo a public or private company?
Bionexo is a private company.
What is the current stock price of Bionexo?
Bionexo is a private company with no public stock price. No recent secondary market data is available.
How much is Bionexo worth (valuation)?
Bionexo's valuation is estimated at $200.2M based on funding round data.
Can I buy Bionexo stock?
Bionexo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Bionexo's last funding round?
Bionexo's most recent funding round was Growth Equity on October 15, 2021.
Who are the main investors in Bionexo?
Key investors in Bionexo include Bain Capital, LP, Insight Partners, Prisma Capital.
Will Bionexo IPO soon?
No public IPO plans have been announced for Bionexo.
How can I track Bionexo secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Bionexo's secondary market activity and sign up for updates.